SEP 20, 2016 7:00 AM PDT

Advanced Analysis of Complex Cell Models with the New Operetta CLS HCA System

Speakers
  • Senior Field Applications Scientist, PerkinElmer
    Biography
      Joe joined PerkinElmer in July 2016 and is instrumental in strategic customer support through teaching, training, and collaborations. He brings over 20 years of experience in high content screening technology from academia (Duke University and The Ohio State University), pharmaceutical industry (Abbott Laboratories and Sphinx Laboratories, Division of Eli Lilly & Company), and biotechnology (The Hamner Institute for Health Sciences and ScitoVation). Joe has extensive experience in cell based technologies from flow cytometry, confocal microscopy and computer-assisted automated microscopy studying cancer, immunology, neurodegeneration, and toxicology. Joe has published several research articles and book chapters in High Content Imaging field, and is an author and co-editor to the NIH/NCATS Assay Guidance Manual. Joe was a co-founder and first President of Society for Biomolecular Imaging and Informatics (SBI2).
    • Portfolio Director, PerkinElmer
      Biography
        As portfolio director for high content instruments, Dr. Tesdorpf is leading the global product management and application development for high content screening and live cell imaging at PerkinElmer. He holds a doctorate in biochemistry from Hannover University and did research on nuclear hormone receptors at the Max-Planck-Institute. Dr. Tesdorpf held several imaging related sales and marketing roles at Molecular Dynamics, Amersham Biosciences and GE Healthcare looking after proteomics, microarrays, pre-clinical imaging and high content analysis software. Prior to joining PerkinElmer in 2010 Dr. Tesdorpf headed the marketing group at 5 PRIME GmbH a supplier of nucleic acid purification and amplification products.

      Abstract
      DATE: September 20th, 2016
      TIME:  7:00AM PST, 10:00AM ET


      There is a growing trend towards developing in vitro cell models that recapitulate the in vivo environment in basic research, developmental biology, drug discovery, and toxicology. To achieve this, scientists are using more complex cellular models such as ex vivo tissue, primary cells, stem cells, or a combination of co-culture cells to form 3D structures or scaffolds to generate detailed phenotypic fingerprints for deeper biological insights in both live cell and fixed endpoint assays.
       
      In this webinar, we will show how the advanced features of the new Operetta CLSTM high-content analysis system from PerkinElmer can help you to achieve the throughput to assess varied conditions, the resolution to capture high-quality image data and insights from the data.   

       
      Key Learning Objectives
      What you will learn:
      • How you can achieve increased sensitivity, speed and quality when imaging 3D microtissues such as liver cells and stem cell colonies
      • Advantages of the confocality, high NA water immersion objectives and powerful  8-color LED excitation provided by the Operetta CLS system
      • How the intelligent scanning software feature - PreciScan - enables more efficient screening of 3D microtissues
      • Tools to develop assays for complex biological designs including 3D image capture
       
      Who should attend
      Researchers who are interested in:
      • High-content imaging and analysis
      • Complex cell models for generating more physiologically relevant data
      • Developmental biology, oncology, neurobiology, toxicology, stem cell research
      • Systems biology and phenotypic fingerprinting
      • Advanced cell-based assays

      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
      DEC 02, 2020 8:00 AM PST
      C.E. CREDITS
      DEC 02, 2020 8:00 AM PST
      DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      MAR 16, 2021 10:00 AM PDT
      C.E. CREDITS
      MAR 16, 2021 10:00 AM PDT
      Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
      Loading Comments...
      Show Resources